157 related articles for article (PubMed ID: 3287971)
61. Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections.
Abbruzzese JL; Rocco LE; Laskin OL; Skubitz KM; McGaughey MD; Lipsky JJ
Am J Med; 1983 Apr; 74(4):694-9. PubMed ID: 6220603
[TBL] [Abstract][Full Text] [Related]
62. Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Stellato TA; Danziger LH; Hau T; Gauderer MW; Ferron JL; Gordon N
Arch Surg; 1988 Jun; 123(6):714-7. PubMed ID: 3285809
[TBL] [Abstract][Full Text] [Related]
63. Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections.
Sweet RL; Ohm-Smith M; Landers DV; Robbie MO
Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):808-17. PubMed ID: 3895947
[TBL] [Abstract][Full Text] [Related]
64. [Septicemia and focal infection. Efficacy of moxalactam. Results of the cooperative study conducted in France].
Carbon C
Sem Hop; 1983 Jun; 59(26):1981-4. PubMed ID: 6310791
[No Abstract] [Full Text] [Related]
65. Cefotetan: a review of the microbiologic properties and antimicrobial spectrum.
Jones RN
Am J Surg; 1988 May; 155(5A):16-23. PubMed ID: 3287964
[TBL] [Abstract][Full Text] [Related]
66. Efficacy of liposomal antibiotic therapy in a rat infusion model of Escherichia coli peritonitis.
Martineau L; Shek PN
Crit Care Med; 1999 Jun; 27(6):1153-8. PubMed ID: 10397221
[TBL] [Abstract][Full Text] [Related]
67. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH
Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981
[TBL] [Abstract][Full Text] [Related]
68. Moxalactam: clinical summary of efficacy and safety.
Kammer RB
Rev Infect Dis; 1982; 4 Suppl():S712-9. PubMed ID: 6218589
[TBL] [Abstract][Full Text] [Related]
69. A comparison of cefotetan and cephazolin for prophylaxis against wound infection after elective cholecystectomy.
Drumm J; Donovan IA; Wise R
J Hosp Infect; 1985 Sep; 6(3):277-80. PubMed ID: 2865292
[TBL] [Abstract][Full Text] [Related]
70. Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.
Brook I
Clin Infect Dis; 1995 Jun; 20 Suppl 2():S376-7. PubMed ID: 7548603
[No Abstract] [Full Text] [Related]
71. Antibiotic efficacy in intraabdominal sepsis: a clinically relevant model.
Bohnen JM; Matlow AG; Mustard RA; Christie NA; Kavouris B
Can J Microbiol; 1988 Mar; 34(3):323-6. PubMed ID: 3416240
[TBL] [Abstract][Full Text] [Related]
72. Therapeutic approaches to anaerobic infection.
Tally FP
Hosp Pract (Off Ed); 1981 Dec; 16(12):117-24, 129-32. PubMed ID: 6458550
[No Abstract] [Full Text] [Related]
73. Use of cephalosporins with enhanced anti-anaerobic activity for treatment and prevention of anaerobic and mixed infections.
DiPiro JT; May JR
Clin Pharm; 1988 Apr; 7(4):285-302. PubMed ID: 3284692
[TBL] [Abstract][Full Text] [Related]
74. Pharmacokinetics and clinical efficacy of moxalactam in biliary tract infections.
Mueller O; Fabricius K; Krueger E; Rueckert U
Rev Infect Dis; 1982; 4 Suppl():S688-91. PubMed ID: 6218584
[TBL] [Abstract][Full Text] [Related]
75. Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.
Senft HH; Stiglmayer R; Eibach HW; Koerner H
Drugs; 1986; 31 Suppl 2():18-21. PubMed ID: 3013568
[TBL] [Abstract][Full Text] [Related]
76. In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
Daschner FD; Goerke C; Bassler M; Just M
Chemotherapy; 1982; 28(5):351-4. PubMed ID: 6958416
[TBL] [Abstract][Full Text] [Related]
77. Moxalactam therapy for a wide spectrum of bacterial infections in adults.
Tofte RW; Rotschafer J; Solliday J; Crossley KB
Antimicrob Agents Chemother; 1981 May; 19(5):740-4. PubMed ID: 6457555
[TBL] [Abstract][Full Text] [Related]
78. Moxalactam in the therapy of serious infections.
Marier RL; Faro S; Sanders CV; Williams W; Derks F; Janney A; Aldridge K
Antimicrob Agents Chemother; 1982 Apr; 21(4):650-4. PubMed ID: 6211140
[TBL] [Abstract][Full Text] [Related]
79. [Clinical experience with moxalactam in the treatment of mixed aerobic-anaerobic surgical infections].
Gonzenbach HR; Sonnabend W
Schweiz Rundsch Med Prax; 1983 Mar; 72(11):356-62. PubMed ID: 6221243
[No Abstract] [Full Text] [Related]
80. Use of moxalactam for bacterial meningitis.
Kaplan SL; Mason EO; Feigin RD
J Pediatr; 1982 May; 100(5):843. PubMed ID: 6461736
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
